Market Closed -
Euronext Paris
09:05:24 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
3.15
EUR
|
-2.63%
|
|
-17.21%
|
-52.99%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
211.8
|
242.7
|
358.5
|
312.3
|
204.6
|
78.06
|
78.06
|
-
|
Enterprise Value (EV)
1 |
191.2
|
203.6
|
361.4
|
325.1
|
208.5
|
165.8
|
147
|
190.1
|
P/E ratio
|
-5.22
x
|
-5.7
x
|
-9.93
x
|
-5.13
x
|
-4.4
x
|
-1.52
x
|
-2.66
x
|
-3.44
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
347
x
|
-
|
142
x
|
682
x
|
59.2
x
|
3.39
x
|
1.93
x
|
EV / Revenue
|
-
|
291
x
|
-
|
148
x
|
695
x
|
59.2
x
|
6.38
x
|
4.69
x
|
EV / EBITDA
|
-4.65
x
|
-4.94
x
|
-13.1
x
|
-6.37
x
|
-4.15
x
|
-2.97
x
|
-4.74
x
|
-13.4
x
|
EV / FCF
|
-4.72
x
|
-4.98
x
|
-6.65
x
|
-5.25
x
|
-3.71
x
|
-3.13
x
|
-2.74
x
|
-5.29
x
|
FCF Yield
|
-21.2%
|
-20.1%
|
-15%
|
-19%
|
-26.9%
|
-32%
|
-36.4%
|
-18.9%
|
Price to Book
|
29.1
x
|
6.24
x
|
47.2
x
|
330
x
|
14.3
x
|
-1.9
x
|
-1.19
x
|
-0.78
x
|
Nbr of stocks (in thousands)
|
9,014
|
12,590
|
12,667
|
15,349
|
19,615
|
24,782
|
24,782
|
-
|
Reference price
2 |
23.50
|
19.28
|
28.30
|
20.35
|
10.43
|
3.150
|
3.150
|
3.150
|
Announcement Date
|
13/02/19
|
12/02/20
|
10/02/21
|
16/02/22
|
23/02/23
|
24/04/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
0.7
|
-
|
2.2
|
0.3
|
2.8
|
23.05
|
40.52
|
EBITDA
1 |
-41.13
|
-41.23
|
-27.58
|
-51.08
|
-50.24
|
-43.03
|
-31
|
-14.15
|
EBIT
1 |
-42.77
|
-42.4
|
-36.4
|
-52.4
|
-51.9
|
-52.5
|
-45.2
|
-36.61
|
Operating Margin
|
-
|
-6,057.14%
|
-
|
-2,381.82%
|
-17,300%
|
-1,875%
|
-196.07%
|
-90.34%
|
Earnings before Tax (EBT)
1 |
-43.71
|
-44.2
|
-38.9
|
-63.74
|
-55.77
|
-57.61
|
-56.31
|
-46.89
|
Net income
1 |
-41.73
|
-42.6
|
-37
|
-61.9
|
-53.7
|
-53.9
|
-38
|
-32.05
|
Net margin
|
-
|
-6,085.71%
|
-
|
-2,813.64%
|
-17,900%
|
-1,925%
|
-164.84%
|
-79.1%
|
EPS
2 |
-4.500
|
-3.380
|
-2.850
|
-3.970
|
-2.370
|
-2.069
|
-1.185
|
-0.9150
|
Free Cash Flow
1 |
-40.47
|
-40.89
|
-54.37
|
-61.93
|
-56.12
|
-40.83
|
-53.55
|
-35.95
|
FCF margin
|
-
|
-5,841.96%
|
-
|
-2,815.09%
|
-18,707.67%
|
-503.92%
|
-232.32%
|
-88.71%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
13/02/19
|
12/02/20
|
10/02/21
|
16/02/22
|
23/02/23
|
24/04/24
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 Q1
|
2021 Q2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 S2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
1.1
|
1.1
|
2.2
|
0.06
|
0.06
|
-
|
-
|
0.3
|
0.6
|
5.5
|
8
|
5.05
|
-
|
-
|
5.49
|
-
|
12.61
|
21.92
|
35.39
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-20.6
|
-15.8
|
-12.77
|
-12.77
|
-25.5
|
-13.38
|
-13.38
|
-26.9
|
-12.54
|
-12.54
|
-25.1
|
-
|
-26.8
|
-
|
-12.56
|
-10.06
|
-33.37
|
-
|
-
|
-26.1
|
-
|
-25.99
|
-23.54
|
-18.88
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-1,216.36%
|
-1,216.36%
|
-1,222.73%
|
-20,900%
|
-20,900%
|
-
|
-
|
-8,933.33%
|
-
|
-228.45%
|
-125.81%
|
-660.79%
|
-
|
-
|
-475.41%
|
-
|
-206.11%
|
-107.39%
|
-53.35%
|
Earnings before Tax (EBT)
1 |
-21.61
|
-17.3
|
-13.51
|
-13.51
|
-
|
-18.39
|
-18.39
|
-36.71
|
-13.47
|
-13.47
|
-26.9
|
-
|
-
|
-
|
-13.52
|
-11.02
|
-35.46
|
-
|
-
|
-28.11
|
-
|
-28.21
|
-25.71
|
-21.18
|
Net income
1 |
-20.8
|
-16.2
|
-13.18
|
-13.18
|
-26.4
|
-17.77
|
-17.77
|
-35.5
|
-13
|
-13
|
-26
|
-
|
-
|
-26.7
|
-13.52
|
-11.02
|
-31.98
|
-
|
-
|
-24.69
|
-
|
-24.79
|
-23.79
|
-19.27
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-1,615.45%
|
-1,615.45%
|
-1,613.64%
|
-21,666.67%
|
-21,666.67%
|
-
|
-
|
-
|
-4,450%
|
-245.73%
|
-137.69%
|
-633.27%
|
-
|
-
|
-449.73%
|
-
|
-196.59%
|
-108.53%
|
-54.45%
|
EPS
2 |
-
|
-
|
-
|
-
|
-1.713
|
-1.140
|
-1.140
|
-2.257
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.5900
|
-0.4400
|
-1.230
|
-0.3000
|
-0.2300
|
-0.8200
|
-0.1500
|
-0.7300
|
-0.6600
|
-0.4800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
09/09/20
|
10/02/21
|
15/09/22
|
15/09/21
|
15/09/21
|
15/09/22
|
16/02/22
|
16/02/22
|
15/09/22
|
15/09/22
|
15/09/22
|
23/02/23
|
23/02/23
|
25/09/23
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
2.96
|
12.8
|
3.9
|
49.6
|
68.9
|
112
|
Net Cash position
1 |
20.7
|
39.1
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.1072
x
|
-0.2506
x
|
-0.0776
x
|
-1.153
x
|
-2.223
x
|
-7.919
x
|
Free Cash Flow
1 |
-40.5
|
-40.9
|
-54.4
|
-61.9
|
-56.1
|
-40.8
|
-53.6
|
-36
|
ROE (net income / shareholders' equity)
|
-162%
|
-143%
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
0.8100
|
3.090
|
0.6000
|
0.0600
|
0.7300
|
-1.660
|
-2.650
|
-4.030
|
Cash Flow per Share
2 |
-4.190
|
-3.190
|
-4.010
|
-3.240
|
-2.400
|
-1.900
|
-1.030
|
-0.7400
|
Capex
1 |
2.29
|
0.65
|
2.33
|
1.76
|
1.75
|
2.85
|
3.23
|
3.48
|
Capex / Sales
|
-
|
92.68%
|
-
|
80.14%
|
582.67%
|
35.17%
|
14.03%
|
8.57%
|
Announcement Date
|
13/02/19
|
12/02/20
|
10/02/21
|
16/02/22
|
23/02/23
|
24/04/24
|
-
|
-
|
Last Close Price
3.15
EUR Average target price
14.22
EUR Spread / Average Target +351.43% Consensus |
1st Jan change
|
Capi.
|
---|
| -52.99% | 83.34M | | +12.07% | 128B | | -9.04% | 10.65B | | +0.91% | 8.82B | | +16.72% | 7.19B | | +25.15% | 4.99B | | +7.17% | 3.4B | | -1.36% | 3.03B | | -8.73% | 2.14B | | -10.15% | 2B |
Medical Devices & Implants
|